A

Alchemab Therapeutics Ltd

65 employees

Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Pharmaceutical

Date founded

2019

Funding rounds raised

Total raised

$83M

from 8 investors over 8 rounds

A

Alchemab Therapeutics Ltd raised $83M on April 15, 2021

Investors: RA Capital Management, L.P., DHVC, Data Collective, The Dementia Discovery Fund and Lightstone Ventures

A

Alchemab Therapeutics Ltd raised undisclosed on December 1, 2019

Investors: DCVC Bio and The Dementia Discovery Fund

A

Alchemab Therapeutics Ltd raised undisclosed on December 1, 2019

Investors: DCVC Bio

FAQ